How to play the internal rotation in markets
With the seemingly level headed rotation continuing in the markets Chris Temple shares where he thinks opportunity exists. As Chris says he is not going all in but even in the sectors where the underlying asset price continues to be under pressure there are opportunities.
Click here to visit Chris’s site for more great commentary.
Click download link to listen on this device: Download Show
Dropout Rate For Health Law Coverage Is 16 Percent This Year
By RICARDO ALONSO-ZALDIVAR – Associated Press – 33 minutes ago
WASHINGTON (AP) — The Trump administration says nearly 2 million people have dropped their health insurance through the Obama-era law after sign-up season ended Jan. 31. That’s a 16 percent dropout rate.
As of March 15, about 10.3 million were signed up and paying their premiums, according to figures released Monday by the Health and Human Services Department. That’s 1.9 million fewer than the 12.2 million originally signed up for 2017 through HealthCare.gov and state markets offering subsidized private insurance.
The Trump administration says the dropout rate is more evidence that “Obamacare” is failing, but the insurance markets lost customers when Barack Obama was in office — about 13 percent last year.
https://www.youtube.com/watch?v=wIpwKZBAy1Y
Puerto Rico…..
Hard Brexit Soft Brexit ! No Brexit ! Heir comes Boris Johnson ! White A Donald Hair STYLE ! All PLANT NO BREXIT !
I am wary of rotation at the moment – especially into energy stocks, as tempting as some are.
I am just going to hide behind the sofa.
Take a bottle with you it’s ugly .
Oil stocks could go down again if oil drops below 45. I sold a huge xop position too early in the rally at a loss and trying to get back in soon.
Where has Doc been?
SECRET SERVICE……says NO COMEY tapes………….to bad for congress
Way Trump is acting seems likethere are no tapes. Saying i will tell you in a few weeks , seems like they same stuff he did about showing his taxes. former president Warren Harding is starting to creep up the list of presidents from last place to 2nd from last. President Pence coffee mugs now on order. best of health and wealth to you al S
russell……..
Pence mugs to read……..2024………. that is about as close as he gets………lol
US has been going down hill since 1864………
CNN Destroyed By Weather Channel Founder Over Climate Change
I can confirm that I was told to be a good boy and the government would hand me millions of dollars a year to put out studies to support whatever. They tell you what the conclusion is to be and you then write a report that they can claim some expert has derived this as if it is really impartial. They would not let anyone even speak at the Paris Climate Conference who disagreed with them. There are over 31,000 scientists who have stood up and said this is a hoax.
I guess the recent mountain men reality show was all fake news ,The snow pack in alaska really is ok ?? How come the mountain man could not find enough snow to opperate his snow mobile . He had to push it on grass to another location to find more snow . . Climate change is real , Jerry you are believing fake news storys . S
Climate change is always real — REALLY caused primarily by solar cycles. Why do you think the Marxists in charge are trying to shut up those who disagree? If you knew your history, you’d know that the powers that be only attack and silence those who tell a truth that inconveniences them. Of course, if most on the left knew their history, there’d be no left at all.
WASHINGTON (AP) — A unanimous Supreme Court is speeding up the time for generic biotech drugs to become available to the public in a ruling that means a loss of billions in sales to the makers of original versions.
The justices ruled Monday in favor of generic drug maker Sandoz in its dispute with rival Amgen over a near-copy of Amgen’s cancer drug Neupogen.
The case involves biologics — drugs made from living cells instead of chemicals. The drugs have led to major advances in treating diseases, but come at steep prices.
A 2010 law allows cheaper generic versions known as biosimilars to be produced after a 12-year exclusive run for the original.
Writing for the court, Justice Clarence Thomas said the law does not require companies making biosimilars to wait an extra six months after gaining Food and Drug Administration approval before selling the drugs.
The extra time can add billions of dollars in additional sales to the original drug makers before biosimilars enter the market.
The dispute involves the drug Zarxio, a generic that Sandoz developed to compete with Neupogen that sells for about 15 percent less than the original product. The drugs help boost red blood cells in cancer patients.